A recent study has linked a group of over-the-counter drugs to the development of dementia and Alzheimer's in older adults.
Scientists found that the prolonged use of certain drugs, including certain hayfever, incontinence treatments, some sleeping tablets and anti-depressants, can reduce brain size.
Drugs known as anticholinergenics, which block the chemical which transfers electrical impulses between nerves, were also found to lower metabolism.
The Indiana University School of Medicine research used brain-imaging techniques and cognitive tests to assess the 451 elderly participants, of which 60 were taking at least one medication with an anticholinergenic agent.
Those taking the drug had notably reduced brain volume, and larger ventricles and cavities inside the brain.
First author Dr Shannon Risacher said that these findings might give us clues to the biological basis for the cognitive problems associated with anticholinergic drugs, but additional studies are needed if we are to truly understand the mechanisms involved.
The research concluded anticholinergic medicines were "associated with increased brain atrophy and dysfunction and clinical decline" and therefore, "use of [anticholinergic] medication among older adults should likely be discouraged if alternative therapies are available".
The study is published in the journal JAMA Neurology.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
